Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Shutaro, Yamada"'
Autor:
Naohiro Yasuda, Satoshi Takenaka, Sho Nakai, Takaaki Nakai, Shutaro Yamada, Yoshinori Imura, Hidetatsu Outani, Kenichiro Hamada, Hideki Yoshikawa, Norifumi Naka
Publikováno v:
FEBS Open Bio, Vol 10, Iss 5, Pp 767-779 (2020)
Osteosarcoma is the most common malignant bone tumor in adolescence and childhood. Metastatic osteosarcoma has a poor prognosis with an overall 5‐year survival rate of approximately 20%. TAS‐115 is a novel multiple receptor tyrosine kinase inhibi
Externí odkaz:
https://doaj.org/article/5cbf079bfe7f41048f35778ed30cb849
Autor:
Shutaro Yamada, Yoshinori Imura, Takaaki Nakai, Sho Nakai, Naohiro Yasuda, Keiko Kaneko, Hidetatsu Outani, Satoshi Takenaka, Kenichiro Hamada, Akira Myoui, Nobuhito Araki, Takafumi Ueda, Kazuyuki Itoh, Hideki Yoshikawa, Norifumi Naka
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-14 (2017)
Abstract Background The prognosis of synovial sarcoma (SS), an aggressive soft tissue sarcoma, remains poor. We previously reported that c-MET or platelet-derived growth factor receptor α (PDGFRα) signalling pathway is related to SS progression bas
Externí odkaz:
https://doaj.org/article/0a9f7289c3704ad280f60fd471aef4c1
Autor:
Sho Nakai, Naohiro Yasuda, Satoshi Takenaka, Norifumi Naka, Takaaki Nakai, Yoshinori Imura, Shutaro Yamada, Hidetatsu Outani, Hideki Yoshikawa, Kenichiro Hamada
Publikováno v:
FEBS Open Bio, Vol 10, Iss 5, Pp 767-779 (2020)
FEBS Open Bio
FEBS Open Bio
Osteosarcoma is the most common malignant bone tumor in adolescence and childhood. Metastatic osteosarcoma has a poor prognosis with an overall 5‐year survival rate of approximately 20%. TAS‐115 is a novel multiple receptor tyrosine kinase inhibi
Autor:
Yoshihiro Mukai, Daisuke Ikegami, Takahito Fujimori, Tsuyoshi Sugiura, Hironobu Sakaura, Shutaro Yamada
Publikováno v:
Clinical neurology and neurosurgery. 209
Objective To investigate whether or not the fusion rate after posterior lumbar interbody fusion with cortical bone trajectory screw fixation (CBT-PLIF) is lower than after PLIF using traditional trajectory screw fixation (TT-PLIF) and whether or not
Autor:
Shohei Otsuki, Haruhiko Kashiwazaki, Shinsuke Mizutani, Kyohei Kubo, Shutaro Yamada, Saori Oku, Kiyomi Iyota, Yoshihiro Kobayashi
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 17, Iss 4863, p 4863 (2020)
International Journal of Environmental Research and Public Health
Volume 17
Issue 13
International Journal of Environmental Research and Public Health
Volume 17
Issue 13
The aim of this cross-sectional study was to investigate the association between oral function and oral health-related quality of life (OHRQoL) in healthy university students. Oral functions and OHRQoL (General Oral Health Assessment Index
GOHAI
GOHAI
Autor:
Hidetatsu Outani, Sho Nakai, Takafumi Ueda, Kazuyuki Itoh, Satoshi Takenaka, Norifumi Naka, Takaaki Nakai, Shutaro Yamada, Naohiro Yasuda, Yoshinori Imura, Keiko Kaneko, Hideki Yoshikawa, Nobuhito Araki, Kenichiro Hamada, Akira Myoui, Hironari Tamiya
Publikováno v:
Cancer Medicine
Clear cell sarcoma is an aggressive soft tissue sarcoma and highly resistant to conventional chemotherapy and radiation therapy. This devastating disease is defined by EWSR1‐ATF1 fusion gene resulting from chromosomal translocation t(12;22)(q13;q12
Autor:
Sho, Nakai, Shutaro, Yamada, Hidetatsu, Outani, Takaaki, Nakai, Naohiro, Yasuda, Hirokazu, Mae, Yoshinori, Imura, Toru, Wakamatsu, Hironari, Tamiya, Takaaki, Tanaka, Kenichiro, Hamada, Akiyoshi, Tani, Akira, Myoui, Nobuhito, Araki, Takafumi, Ueda, Hideki, Yoshikawa, Satoshi, Takenaka, Norifumi, Naka
Publikováno v:
Scientific Reports
Approximately 60-70% of EWSR1-negative small blue round cell sarcomas harbour a rearrangement of CIC, most commonly CIC-DUX
Autor:
Satoru Sasagawa, Akira Myoui, Takaaki Nakai, Shutaro Yamada, Kenichiro Hamada, Satoshi Takenaka, Nobuhito Araki, Norifumi Naka, Hidetatsu Outani, Yoshinori Imura, Kazuyuki Itoh, Hirohiko Yasui, Hideki Yoshikawa
Publikováno v:
Journal of Chemotherapy. 28:417-424
Synovial sarcoma (SS) is an aggressive soft tissue tumour with poor prognosis. Using five human SS cell lines, we examined the cytotoxic effects of trabectedin (ET-743; Yondelis(®)), a novel marine natural product, which was approved in Europe for t
Autor:
Takafumi Ueda, Yoshinori Imura, Toru Wakamatsu, Hirokazu Mae, Takaaki Tanaka, Hidetatsu Outani, Nobuhito Araki, Satoshi Takenaka, Hideki Yoshikawa, Norifumi Naka, Kenichiro Hamada, Akiyoshi Tani, Takaaki Nakai, Naohiro Yasuda, Shutaro Yamada, Sho Nakai, Akira Myoui, Hironari Tamiya
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Autor:
Keiko Kaneko, Satoshi Takenaka, Norifumi Naka, Nobuhito Araki, Shutaro Yamada, Hidetatsu Outani, Takaaki Nakai, Sho Nakai, Takafumi Ueda, Kazuyuki Itoh, Kenichiro Hamada, Hideki Yoshikawa, Naohiro Yasuda, Yoshinori Imura, Akira Myoui
Publikováno v:
BMC Cancer
BMC Cancer, Vol 17, Iss 1, Pp 1-14 (2017)
BMC Cancer, Vol 17, Iss 1, Pp 1-14 (2017)
Background The prognosis of synovial sarcoma (SS), an aggressive soft tissue sarcoma, remains poor. We previously reported that c-MET or platelet-derived growth factor receptor α (PDGFRα) signalling pathway is related to SS progression based upon t